Scholarlink

<p>Immunosuppressed (IS) patients are at an increased risk of developing nonmelanoma skin cancers compared to immunocompetent (IC) patients. The standard of treatment in both cohorts is Mohs Micrographic Surgery (MMS); however, the impact and prognosis of MMS in IS patients has not been comprehensively characterized. This review elucidates post-MMS complications, recurrence, metastasis, and survival in IS patients with cutaneous malignancies. Results have important implications for pre-operative planning, and post-operative surveillance and management of IS patients with cutaneous malignancies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Mohs Micrographic Surgery (MMS) in immunosuppressed patients: a review of outcomes and prognosis

  • 期刊论文

  • 发表日期：

    2025年5月16日

查看全文
  • Maira A. Bhatty,
  • Micah Belzberg,
  • Allison T. Vidimos,
  • Christine Poblete-Lopez

摘要

Immunosuppressed (IS) patients are at an increased risk of developing nonmelanoma skin cancers compared to immunocompetent (IC) patients. The standard of treatment in both cohorts is Mohs Micrographic Surgery (MMS); however, the impact and prognosis of MMS in IS patients has not been comprehensively characterized. This review elucidates post-MMS complications, recurrence, metastasis, and survival in IS patients with cutaneous malignancies. Results have important implications for pre-operative planning, and post-operative surveillance and management of IS patients with cutaneous malignancies.